Long Non-coding RNA XIST Promotes Osteoporosis by Inhibiting the Differentiation of Bone Marrow Mesenchymal Stem Cell by Sponging MiR-29b-3p That Suppresses Nicotinamide N-methyltransferase

Overview

Journal Bioengineered

Date 2021 Sep 6

PMID 34486487

Citations 14

Authors

Jiang Yu

Min Xiao

Guohai Ren

Affiliations

Soon will be listed here.

Abstract

Bone formation is important in the development of osteoporosis (OP). X-inactive specific transcript (XIST), a lncRNA, is involved in this process; however, mode of its action is not known. We compared the serum levels of XIST and miR-29b-3p among the patients with and without OP. In rat bone marrow mesenchymal stem cells (BMSCs), during osteogenic differentiation, XIST expression was detected first, followed by overexpression or suppression of miR-29b-3p and NNMT. Expression of osteogenic genes, ALP (electrochemical alkaline phosphatase) and RUNX2 (Runt-related transcription factor 2) were detected by RT-qPCR and western blots, and the calcium nodules in BMSCs were detected by staining. The relationships of XIST, miR-29b-3p, and NNMT were characterized by dual-luciferase reporter assay. Serum XIST was significantly upregulated in patients of OP. XIST downregulated the ALP and Runx2 levels and inhibited calcium nodules, whereas low expression of XIST reversed these events. MiR-29b-3p was inhibited by XIST sponge and lowered the levels of ALP, Runx2, and calcium nodules. NNMT was negatively regulated by miR-29b-3p, promoting the osteogenic differentiation of BMSCs. In conclusion, XIST is highly expressed in OP, and regulates NNMT by sponging miR-29b-3p to suppress the osteogenic differentiation of BMSCs.

Citing Articles

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome.

Sun W, Zhu X, Li J, Mei Y, Li W, Li J Front Pharmacol. 2024; 15:1410479.

PMID: 38919254 PMC: 11196770. DOI: 10.3389/fphar.2024.1410479.

LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate.

Gordon J, Tye C, Banerjee B, Ghule P, van Wijnen A, Kabala F Sci Rep. 2023; 13(1):20314.

PMID: 37985890 PMC: 10662126. DOI: 10.1038/s41598-023-46202-z.

Common miRNAs of Osteoporosis and Fibromyalgia: A Review.

Philippe S, Delay M, Macian N, Morel V, Pickering M Int J Mol Sci. 2023; 24(17).

PMID: 37686318 PMC: 10488272. DOI: 10.3390/ijms241713513.

Research progress on the role of lncRNA-miRNA networks in regulating adipogenic and osteogenic differentiation of bone marrow mesenchymal stem cells in osteoporosis.

An F, Wang X, Wang C, Liu Y, Sun B, Zhang J Front Endocrinol (Lausanne). 2023; 14:1210627.

PMID: 37645421 PMC: 10461560. DOI: 10.3389/fendo.2023.1210627.

The lncRNA XIST/miR-29b-3p/COL3A1 axis regulates central carbon metabolism in head and neck squamous cell carcinoma and is associated with poor tumor prognosis.

Li Q, Miao J, Shi N, Lin C, Hu X, Shen Y Ann Transl Med. 2023; 11(4):165.

PMID: 36923098 PMC: 10009572. DOI: 10.21037/atm-23-30.

References

Hardison J . Sounding boards. To be complete. N Engl J Med. 1979; 300(4):193-4. DOI: 10.1056/NEJM197901253000410. View

Maluta T, Toso G, Negri S, Samaila E, Magnan B . Correlation between hip osteoarthritis and proximal femoral fracture site: could it be protective for intracapsular neck fractures? A retrospective study on 320 cases. Osteoporos Int. 2019; 30(8):1591-1596. DOI: 10.1007/s00198-019-05015-5. View

Golub E, Harrison G, Taylor A, Camper S, Shapiro I . The role of alkaline phosphatase in cartilage mineralization. Bone Miner. 1992; 17(2):273-8. DOI: 10.1016/0169-6009(92)90750-8. View

Chen S, Li Y, Zhi S, Ding Z, Huang Y, Wang W . lncRNA Xist Regulates Osteoblast Differentiation by Sponging miR-19a-3p in Aging-induced Osteoporosis. Aging Dis. 2020; 11(5):1058-1068. PMC: 7505278. DOI: 10.14336/AD.2019.0724. View

Feichtinger X, Muschitz C, Heimel P, Baierl A, Fahrleitner-Pammer A, Redl H . Bone-related Circulating MicroRNAs miR-29b-3p, miR-550a-3p, and miR-324-3p and their Association to Bone Microstructure and Histomorphometry. Sci Rep. 2018; 8(1):4867. PMC: 5861059. DOI: 10.1038/s41598-018-22844-2. View

Kilgour M, MacPherson S, Zacharias L, Ellis A, Sheldon R, Liu E . 1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer. Sci Adv. 2021; 7(4). PMC: 7817098. DOI: 10.1126/sciadv.abe1174. View

Su P, Tian Y, Yang C, Ma X, Wang X, Pei J . Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy. Int J Mol Sci. 2018; 19(8). PMC: 6121650. DOI: 10.3390/ijms19082343. View

Wang Y, Hu Y, Guo J, Wang L . miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1. Genet Test Mol Biomarkers. 2019; 23(2):98-104. DOI: 10.1089/gtmb.2018.0285. View

Rachner T, Khosla S, Hofbauer L . Osteoporosis: now and the future. Lancet. 2011; 377(9773):1276-87. PMC: 3555696. DOI: 10.1016/S0140-6736(10)62349-5. View

10.

Li J, Liang X, Luo D, Yan B, Liu J, Li G . Study on the molecular mechanism of BuShenHuoXue capsule in treatment of steroid-induced osteonecrosis of the femoral head. Ann Transl Med. 2021; 8(24):1680. PMC: 7812223. DOI: 10.21037/atm-20-7040. View

11.

Mao Q, Liang X, Wu Y, Pang Y, Zhao X, Lu Y . ILK promotes survival and self-renewal of hypoxic MSCs via the activation of lncTCF7-Wnt pathway induced by IL-6/STAT3 signaling. Gene Ther. 2019; 26(5):165-176. DOI: 10.1038/s41434-018-0055-2. View

12.

Zhang X, Cui Y, Ding X, Liu S, Han B, Duan X . Analysis of mRNA‑lncRNA and mRNA‑lncRNA-pathway co‑expression networks based on WGCNA in developing pediatric sepsis. Bioengineered. 2021; 12(1):1457-1470. PMC: 8806204. DOI: 10.1080/21655979.2021.1908029. View

13.

Materozzi M, Merlotti D, Gennari L, Bianciardi S . The Potential Role of miRNAs as New Biomarkers for Osteoporosis. Int J Endocrinol. 2018; 2018:2342860. PMC: 5960506. DOI: 10.1155/2018/2342860. View

14.

Bayani J, Kuzmanov U, Saraon P, Fung W, Soosaipillai A, Squire J . Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression. Clin Chem. 2012; 59(1):296-305. DOI: 10.1373/clinchem.2012.193060. View

15.

Agrawal Singh S, Lerdrup M, Gomes A, Van de Werken H, Johansen J, Andersson R . PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells. Elife. 2019; 8. PMC: 6344081. DOI: 10.7554/eLife.40364. View

16.

Zhang Y, Chen B, Li D, Zhou X, Chen Z . LncRNA NEAT1/miR-29b-3p/BMP1 axis promotes osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. Pathol Res Pract. 2019; 215(3):525-531. DOI: 10.1016/j.prp.2018.12.034. View

17.

Giannoudis P, Jones E, Einhorn T . Fracture healing and bone repair. Injury. 2011; 42(6):549-50. DOI: 10.1016/j.injury.2011.03.037. View

18.

Kannt A, Rajagopal S, Hallur M, Swamy I, Kristam R, Dhakshinamoorthy S . Novel Inhibitors of Nicotinamide--Methyltransferase for the Treatment of Metabolic Disorders. Molecules. 2021; 26(4). PMC: 7918612. DOI: 10.3390/molecules26040991. View

19.

Zhang X, Wang W, Wang Y, Zhao H, Han X, Zhao T . Extracellular Vesicle-Encapsulated miR-29b-3p Released From Bone Marrow-Derived Mesenchymal Stem Cells Underpins Osteogenic Differentiation. Front Cell Dev Biol. 2021; 8:581545. PMC: 7862561. DOI: 10.3389/fcell.2020.581545. View

20.

Enomoto H, Furuichi T, Zanma A, Yamana K, Yoshida C, Sumitani S . Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J Cell Sci. 2004; 117(Pt 3):417-25. DOI: 10.1242/jcs.00866. View